Evidence map›Paper›PMID 34853988›Full record

ArticleBreast cancer research and treatment2022

The impact of the COVID-19 pandemic on perceived access to health care and preferences for health care provision in individuals (being) treated for breast cancer.

Dieuwke R Mink van der Molen, Claudia A Bargon, Marilot C T Batenburg, Lilianne E van Stam, Iris E van Dam, Inge O Baas, Miranda F Ernst, Wiesje Maarse, Maartje Sier, Ernst J P Schoenmaeckers and 7 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Breast cancer research and treatment, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 1 country.

Dieuwke R Mink van der MolenDivision of Imaging and Oncology, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. D.R.MinkvanderMolen-2@umcutrecht.nl.ORCID https://orcid.org/0000-0003-2183-0479
Claudia A BargonDivision of Imaging and Oncology, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
Marilot C T BatenburgDivision of Imaging and Oncology, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
Lilianne E van StamDivision of Imaging and Oncology, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
Iris E van DamDepartment of Radiation Oncology, University Medical Centre Utrecht, Cancer Centre, Utrecht, The Netherlands.
Inge O BaasDepartment of Medical Oncology, University Medical Centre Utrecht, Cancer Centre, Utrecht, The Netherlands.
Miranda F ErnstDepartment of Surgery, Alexander Monro Clinics, Bilthoven, The Netherlands.
Wiesje MaarseDepartment of Plastic, Reconstructive and Hand Surgery, University Medical Centre Utrecht, Utrecht, The Netherlands.
Maartje SierDepartment of Surgery, Rivierenland Hospital, Tiel, The Netherlands.
Ernst J P SchoenmaeckersDepartment of Surgery, Meander Medical Centre, Amersfoort, The Netherlands.
Thijs van DalenDepartment of Surgery, Diakonessenhuis Utrecht, Utrecht, The Netherlands.
Rhodé M BijlsmaDepartment of Medical Oncology, University Medical Centre Utrecht, Cancer Centre, Utrecht, The Netherlands.
Annemiek DoeksenDepartment of Surgery, St. Antonius Hospital, Utrecht, The Netherlands.
Femke van der LeijDepartment of Radiation Oncology, University Medical Centre Utrecht, Cancer Centre, Utrecht, The Netherlands.
Danny A Young-AfatDepartment of Plastic, Reconstructive and Hand Surgery, Amsterdam University Medical Centre, Amsterdam, The Netherlands.
Helena M VerkooijenDivision of Imaging and Oncology, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. H.M.Verkooijen@umcutrecht.nl.
on behalf of UMBRELLA study group
University Medical Center Utrecht · NLAlexander Monro Ziekenhuis · NLDiakonessenhuis hospital · NLMeander Medisch Centrum · NLSt. Antonius Ziekenhuis · NLUniversity of Amsterdam · NLUtrecht University · NLZiekenhuis Rivierenland · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate perceived access to health care and preferences for health care provision among patients (being) treated for breast cancer during the COVID-19 pandemic.

methodsLongitudinal study within the prospective, multicenter UMBRELLA cohort of patients (being) treated for breast cancer. All cohort participants enrolled in UMBRELLA between October 2013 and November 2020 were sent a COVID-19-specific survey during the first and second wave of the COVID-19 pandemic, i.e., April 2020 and November 2020, respectively.

resultsIn total, 1106 (69.3%) and 822 (50.9%) cohort participants completed the survey in the first and second wave, respectively. The proportion of patients experiencing that their treatment or follow-up care was affected due to COVID-19 decreased from 28.4% (n = 198) in April 2020 to 14.8% (n = 103) in November 2020. Throughout the pandemic, one or more hospital consultations were postponed in 10.0% (n = 82) of all patients and changed into a teleconsultation in 23.1% (n = 190). The proportion of patients who experienced a higher threshold to contact their general practitioner due to COVID-19 decreased from 29.9% (n = 204) in the first wave to 20.8% (n = 145) in the second wave. In-person consultations remained most preferred in 35.2% (n = 289) of all patients. Nearly half of all patients (48.3%, n = 396) indicated that telehealth would be a useful alternative for in-person consultations in future.

conclusionPerceived access to health care has improved substantially throughout the pandemic. Digital care is well received by patients (being) treated for breast cancer.

Indexed as

Breast NeoplasmsCOVID-19FemaleHealth Services AccessibilityHumansLongitudinal StudiesPandemicsProspective StudiesSARS-CoV-2Breast cancerCorona virusCOVID-19PandemicSARS-CoV-2

Identifiers

PMID34853988
PMCPMC8635319
OpenAlexW3215896140

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.